Orthocell welcomed 9 News journalist Michael Stamp to Orthocell HQ last week to film an in-depth segment about our FDA clearance for the nightly news.
The feature highlighted how our Remplir nerve repair technology is poised to transform treatment options for peripheral nerve injuries in the US market and beyond. The segment also provided viewers with a behind-the-scenes look at our state-of-the-art manufacturing facilities where this Australian innovation is produced.
The story features a powerful interview with Remplir clinical trial participant Liam Shepard, who shared insight into his remarkable recovery following treatment. Liam’s experience demonstrates the life-changing impact our technology can have for patients suffering from debilitating injuries.
Take a look: